title: The mitochondrial permeability transition pore as a target for cardioprotection in hypertrophic cardiomyopathy.
authors: The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, London WC1E 6HX, UK.
authors: P S C
authors: PS
authors: Rees
authors: S M
authors: SM
authors: Davidson
authors: S E
authors: SE
authors: Harding
authors: C
authors: C
authors: McGregor
authors: P M
authors: PM
authors: Elliot
authors: D M
authors: DM
authors: Yellon
authors: D J
authors: DJ
authors: Hausenloy
mesh_terms: D000069059:Atorvastatin; D002312:Cardiomyopathy, Hypertrophic / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D002316:Cardiotonic Agents / Q000494:pharmacology; D002478:Cells, Cultured; D016572:Cyclosporine / Q000494:pharmacology; D006538:Heptanoic Acids / Q000494:pharmacology; D006801:Humans; D015640:Ion Channel Gating / Q000187:drug effects*; D053078:Membrane Potential, Mitochondrial / Q000187:drug effects; D018613:Microscopy, Confocal; D008929:Mitochondria, Heart / Q000187:drug effects* / Q000378:metabolism; D033681:Mitochondrial Membrane Transport Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism*; D000083162:Mitochondrial Permeability Transition Pore; D015428:Myocardial Reperfusion Injury / Q000209:etiology / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control*; D032383:Myocytes, Cardiac / Q000187:drug effects / Q000378:metabolism; D011758:Pyrroles / Q000494:pharmacology; D013997:Time Factors
chemical_list: D002316:Cardiotonic Agents; D006538:Heptanoic Acids; D033681:Mitochondrial Membrane Transport Proteins; D000083162:Mitochondrial Permeability Transition Pore; D011758:Pyrroles; D016572:Cyclosporine; D000069059:Atorvastatin